Myriad Genetics (MYGN) Intangibles (2010 - 2026)

Myriad Genetics has disclosed Intangibles across 17 years of filings, most recently posting $145.7 million for Q1 2026.

• In Q1 2026, Intangibles fell 43.42% year-over-year to $145.7 million; the TTM figure through Mar 2026 stood at $145.7 million (down 43.42% YoY), while the FY2025 annual figure was $153.4 million, down 41.54% from the prior year.
• Intangibles declined to $145.7 million in Q1 2026, from $153.4 million in the prior quarter.
• Over the last five years, Intangibles for MYGN reached as high as $393.6 million in Q1 2022 and fell as low as $145.7 million in Q1 2026.
• The 5-year median for Intangibles is $340.9 million (2024), against an average of $299.2 million.
• Annual changes were most pronounced in 2023 — Intangibles slipped 3.83% — and 2025, when it plunged 47.81%.
• A 5-year view of Intangibles shows it stood at $379.7 million in 2022, then decreased by 7.95% to $349.5 million in 2023, then fell by 24.92% to $262.4 million in 2024, then tumbled by 41.54% to $153.4 million in 2025, then retreated by 5.02% to $145.7 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $145.7 million, $153.4 million, and $163.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.